Centre de Médecine Héraclès
ActiveSummary
Centre de Médecine Héraclès has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €468k and a net result of €130k. Equity is growing by ~19% per year across the filed fiscal years. Its solvency ranks better than 49% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
84
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability91▲+3
Solvency88▲+24
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days acceptable
Liquidity ample (current ratio 5.56 against 1.69 in 2024; short-term debt: 10% and cash: 7.3% of total assets), and 37.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
62.7%
Return on assets
17.4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
27 d late
2023
22 d late
2022
27 d late
2020
31 d late
2019
1 d early
2018
30 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€468k▲ 38.5%
2024 · €338k
2018: €65k
2019: €78k
2020: €124k
2022: €303k
2023: €412k
2024: €338k
2018 → 2025
Total assets
€747k▼ 13.5%
2024 · €863k
2018: €225k
2019: €247k
2020: €401k
2022: €678k
2023: €740k
2024: €863k
2018 → 2025
Net result
€130k▼ 4.2%
2024 · €136k
2018: €26k
2019: €13k
2020: €52k
2022: €85k
2023: €115k
2024: €136k
2018 → 2025
Working capital
€341k▲ 74.0%
2024 · €196k
2018: €16k
2019: €23k
2020: €40k
2022: €102k
2023: €246k
2024: €196k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202022202320242025Trend
Equity€124k-€303k▲ 144%€412k▲ 35.9%€338k▼ 18.0%€468k▲ 38.5%
Operating result€72k-€125k▲ 73.8%€173k▲ 38.7%€197k▲ 13.5%€182k▼ 7.6%
Net result€52k-€85k▲ 63.6%€115k▲ 35.2%€136k▲ 18.0%€130k▼ 4.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 8% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €747k
Fixed assets
€331k ▼ 14.0%
Current assets
€416k ▼ 13.0%
Equity and liabilities €747k
Equity
€468k ▲ 38.5%
Debt
€278k ▼ 46.9%
Debt's share of the balance-sheet total falls from 60.8% to 37.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€236k▼
2024 · €252k
Cash flow
€184k▼
2024 · €191k
Current ratio
5.56▲
2024 · 1.69
Debt to equity
0.59▼
2024 · 1.55
ROE
27.8%▼
2024 · 40.2%
ROA
17.4%▲
2024 · 15.7%
Interest coverage
40.30▲
2024 · 37.86
Debt ≤ 1 year
€75k▼
2024 · €282k
Debt > 1 year
€204k▼
2024 · €235k
Income taxes
€59k▼
2024 · €61k
Staff costs
€16k▲
2024 · €11k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 49 lines
Balance sheet
Code20242025
Assets
Total assets20/58€863k€747k▼
Fixed assets21/28€385k€331k▼
Tangible fixed assets22/27€384k€330k▼
Land and buildings22€125k€120k▼
Plant, machinery and equipment23€241k€202k▼
Furniture and vehicles24€18k€9k▼
Financial fixed assets28€850€850=
Current assets29/58€478k€416k▼
Amounts receivable within one year40/41€119k€350k▲
Trade receivables40€5k€6k▲
Other amounts receivable41€113k€344k▲
Cash at bank and in hand54/58€357k€54k▼
Deferred charges and accrued income490/1€2k€12k▲
Equity and liabilities
Total equity and liabilities10/49€863k€747k▼
Equity10/15€338k€468k▲
Reserves13€338k€468k▲
Distributable reserves133€338k€468k▲
Amounts payable17/49€525k€278k▼
Amounts payable after more than one year17€235k€204k▼
Financial debts170/4€235k€204k▼
Amounts payable within one year42/48€282k€75k▼
Current portion of amounts payable after more than one year42€31k€31k▲
Trade debts44€3k€2k▼
Suppliers440/4€3k€2k▼
Taxes, remuneration and social security45€38k€42k▲
Taxes450/3€37k€40k▲
Remuneration and social security454/9€1k€1k▼
Other amounts payable47/48€210k-
Accrued charges and deferred income492/3€8k€51▼
Income statement
Code20242025
Remuneration, social security and pensions62€11k€16k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€55k€54k▼
Other operating charges640/8€1k€1k▲
Gross operating margin9900€263k€253k▼
Operating profit (loss)9901€197k€182k▼
Financial income75/76B€7k€13k▲
Recurring financial income75€7k€13k▲
Financial charges65/66B€7k€6k▼
Recurring financial charges65€7k€6k▼
Non-recurring financial charges66B-€37
Profit (loss) for the period before taxes9903€197k€189k▼
Income taxes67/77€61k€59k▼
Profit (loss) for the period9904€136k€130k▼
Profit (loss) for the period to be appropriated9905€136k€130k▼
Appropriation of the result
Profit (loss) to be appropriated9906€136k€130k▼
Transfer from equity791/2€210k-
Transfer to equity691/2€136k€130k▼
To other reserves6921€136k€130k▼
Profit to be distributed694/7€210k-
Return on contributions (dividend)694€210k-
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
31-12
Financial
Liquidity triplescurrent ratio 5.56
Current ratio from 1.69 to 5.56; short-term debt falls from €282k to €75k.
27-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 27 days late
2024
31-12
Financial
Highest result since 2018net €136k ▲18%
Operating result €197k, net result €136k, both a record.
22-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 22 days late
2023
31-12
Financial
Liquidity doublescurrent ratio 5.51
Current ratio from 2.40 to 5.51; short-term debt falls from €73k to €55k.
27-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 27 days late
2022
31-12
Financial
Equity above €200kEq €303k ▲144%
4 profitable years in a row build equity to €303k.
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
31-12
Financial
Equity above €100kEq €124k ▲59.7%
3 profitable years in a row build equity to €124k.
30-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Weakest financial yearnet €13k ▼50.7%
Net result drops to €13k, the lowest in the series; recovery starts the following year.
Show earlier events
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
31-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 31 days late
2016
30-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Binche · 1 establishment unit since 2012
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Route de Mons(BIN) 6537130 BincheGround area
1,155 m²
Building footprint
1,034 m²
Volume, LiDAR
5,536 m³
Parcel 55005C0039/00C002, Wallonia · tallest building 8.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Centre de Médecine Héraclès
since 20122.212.943.251
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 55005C0039/00C002 | Wallonia | 1,155 m² | 1 · 1,034 m² | 8.4 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. BIRGIT WIJGAERTS, ALGEMENE GENEESKUNDE
BE 0887.023.131
Lummen · Eq €468,082
DR. CALLANT EWOUT
BE 0791.733.004
Gent · Eq €468,286
Cabinet Médical de la Haute Lesse
BE 0842.493.795
Tellin · Eq €468,358
VIREMED
BE 0741.597.167
Dilsen-Stokkem · Eq €468,367
Dr. L. JANSSEN
BE 0545.971.032
Lummen · Eq €468,437
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 4,943 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded04-09-2012
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.